rdf:type |
|
lifeskim:mentions |
umls-concept:C0003158,
umls-concept:C0003404,
umls-concept:C0034237,
umls-concept:C0039421,
umls-concept:C0220825,
umls-concept:C0332624,
umls-concept:C0376315,
umls-concept:C0701071,
umls-concept:C0870840,
umls-concept:C0871161,
umls-concept:C1521827,
umls-concept:C1527148
|
pubmed:issue |
2
|
pubmed:dateCreated |
1994-11-3
|
pubmed:abstractText |
Manufacturing process for anthelmintic embovin in a micronized form have been developed. Embovin in the micronized form exhibited the highest activity.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0025-8326
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
24-6
|
pubmed:dateRevised |
2009-10-21
|
pubmed:meshHeading |
|
pubmed:articleTitle |
[The technology for manufacturing antiparasitic preparations. 3. The development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|